Suppr超能文献

卡马西平对原发性遗尿症患者尿量、尿渗透压、水清除率及血清渗透压的影响。

Effect of carbamazepine on urinary volume and osmolality, water clearance, and serum osmolality in patients with primary enuresis.

作者信息

Al-Waili Noori S, Al-Waili Hamza, Saloom Khelod Y, Al-Waili Thia, Al-Waili Ali, Akmal Mohammod, Al-Waili Faiza

机构信息

Al-Waili's Charitable Foundation for Science and Trading, New York, NY, USA.

出版信息

Eur Urol. 2006 Oct;50(4):844-9; discussion 849-50. doi: 10.1016/j.eururo.2006.02.040. Epub 2006 Feb 28.

Abstract

OBJECTIVE

In this study we investigate the effects of carbamazepine (CBZ) on urinary volume, frequency of micturition, serum and urine osmolality, osmotic and creatinine clearance, and free water clearance in patients with primary nocturnal enuresis. This information might help in our understanding of the mechanism of action of CBZ in management of patients with enuresis.

PATIENTS AND METHODS

The study comprised eight patients with primary enuresis (age range, 8-14 yr) who wet at night on a daily basis. Enuretics were given, CBZ 200 mg each night; urine volume, urinary osmolality and electrolytes, serum osmolality and electrolytes, osmotic clearance, fractional excretion of sodium, and free water clearance were assayed before CBZ treatment and after 15 d of treatment. Frequencies of bed-wetting and dry nights were observed during treatment.

RESULTS

Mean number (+/-SD) of dry nights was increased from zero dry nights (daily bed-wetting) to 9.7 (2.8) per 15 d of treatment (65%). CBZ decreased the 24-h urinary volume by 41%, the night volume by 45%, the day volume by 38%, and frequency of micturition by 28%. CBZ increased the 24-h urinary osmolality by 43%. Serum osmolality changed significantly from 283.7 mOsm/l to 277.2 mOsm/l. CBZ decreased osmotic clearance by 37% and free water clearance by 34%. Creatinine clearance was decreased by 19% after CBZ treatment (p < 0.05).

CONCLUSION

CBZ reduced urine volume, increased urine osmolality, and decreased the free water clearance, the osmotic clearance, and the frequency of micturition in enuretics; this might help in understanding its mechanism of action.

摘要

目的

在本研究中,我们调查了卡马西平(CBZ)对原发性夜间遗尿症患者尿量、排尿频率、血清和尿液渗透压、渗透清除率和肌酐清除率以及自由水清除率的影响。这些信息可能有助于我们理解CBZ在遗尿症患者管理中的作用机制。

患者与方法

该研究包括8例原发性遗尿症患者(年龄范围8 - 14岁),他们每天夜间尿床。遗尿症患者每晚服用200mg CBZ;在CBZ治疗前和治疗15天后检测尿量、尿渗透压和电解质、血清渗透压和电解质、渗透清除率、钠排泄分数以及自由水清除率。在治疗期间观察尿床和干爽夜晚的频率。

结果

干爽夜晚的平均数量(±标准差)从零个干爽夜晚(每日尿床)增加到每15天治疗期9.7(2.8)个(65%)。CBZ使24小时尿量减少41%,夜间尿量减少45%,白天尿量减少38%,排尿频率减少28%。CBZ使24小时尿渗透压增加43%。血清渗透压从283.7mOsm/l显著变化至277.2mOsm/l。CBZ使渗透清除率降低37%,自由水清除率降低34%。CBZ治疗后肌酐清除率降低19%(p < 0.05)。

结论

CBZ减少了遗尿症患者的尿量,增加了尿渗透压,并降低了自由水清除率、渗透清除率和排尿频率;这可能有助于理解其作用机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验